ClinicalTrials.Veeva

Menu

VR-ACT After Stroke: a Feasibility Study

U

University of Coimbra

Status

Not yet enrolling

Conditions

Stroke
Chronic Pain

Treatments

Behavioral: Sham-VR
Behavioral: VR-ACT

Study type

Interventional

Funder types

Other

Identifiers

NCT06990646
2023.13402.PEX (Other Grant/Funding Number)

Details and patient eligibility

About

This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).

Full description

This project has three objectives: O1) to develop and test the feasibility and acceptability of a 8-week VR ACT program (VR-ACT) in a sample of CPSP patients; O2) to pilot test the efficacy of VR-ACT in improving pain, mental health, and adaptive psychological processes and skills, and in reducing the functional connectivity of the Triple Network (DMN, SN, and FPN); O3) To examine the cost-effectiveness of the VR-ACT. The current project will conduct a parallel group design Randomized Controlled Trial (RCT) and will follow a multi-method approach (qualitative and quantitative assessment).

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • medical diagnosis of CPSP;
  • age between 18 and 80;
  • implicit de facto internet and computer literacy;
  • willingness to comply with the study procedures.

Exclusion criteria

  • currently with active malignancy; -
  • severe cognitive impairment;
  • currently undergoing any psychological intervention or VR-delivered pain management program;
  • current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month);
  • language impairment with severe comprehension deficit;
  • history of photosensitive epilepsy or previous experience of severe simulator sickness;
  • other neurological conditions (e.g., dementia; Parkinson´s).

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

VR-ACT
Experimental group
Description:
8 modules of 3D immersive skills training (2 targeting awareness regulation skills; 3 promoting acceptance; 3 focused on behavioral change and commitment to valued action)
Treatment:
Behavioral: VR-ACT
Sham-VR
Sham Comparator group
Description:
8 2D non-immersive distracting video animations delivered through a VR headset
Treatment:
Behavioral: Sham-VR

Trial contacts and locations

0

Loading...

Central trial contact

Sérgio A Carvalho, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems